Cambridge Heart reports revenue increase, higher net loss

Cambridge Heart has reported total revenue of approximately $2.7 million for third quarter (end-Sept. 30), an increase of 32 percent from total revenue of $2 million reported during the same period of 2006.

The net loss for the quarter was $1.8 million compared to a net loss of about $810,000 in the comparable 2006 period. The operating loss for the third quarter of this year was $2 million, compared to an operating loss of about $900,000 for the same period in 2006, according to the Bedford, Mass.-based company.

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.